American Cynamid Rules!

THE UNANIMITY WITH which Roche and Cipla agreed on the applicability of the American Cyanamid decision and the manner in which the same was applied by the Delhi High Court in the interlocutory stage of the infringement case, reaffirms our faith in the Cyanamid approach. We had earlier remarked here, in the context of the Bajaj-TVS case, on the courts' approach to granting interim injunctions. The Roche-Cipla order illustrates with great clarity on how the Cyanamid approach is to be applied. Unfortunately, we notice that the court did not make any determination on the 'adequacy of damages' which is a vital cog in the Cyanamid approach. My article analysing this issue titled "It's American Cyanamid again on patents vs access to medicines" appeared in today's DNA Money and the same can be read here.